Blood Cancer

AbbVie and Ichnos Glenmark Innovation (IGI) announce exclusive global licensing agreement for ISB 2001, a… AbbVie (Press Release)12:37
Isakrd induction achieves 95% response rate in multiple myeloma Pharmacy Times21:40
FDA approves linvoseltamab for relapsed/Refractory Multiple Myeloma OncLive17:23
The wealth and complexity of treatment options for relapsed/Refractory Multiple Myeloma Medpage Today13:36
Highlighting disparities in myeloma outcomes, the impacts of comorbidities American Journal of Managed Care21:30
Tasquinimod shows some activity in myeloma Medpage Today16:45
JNJ-5322 demonstrates preliminary efficacy and is safe in r/r multiple myeloma OncLive22:18

Latest News

In the last 4 hours

Glenmark to License Blood Cancer Drug to Abbvie for $700 Million Bloomberg Law17:06

In the last 8 hours

AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a… AbbVie (Press Release)12:37

Earlier today

NICE backs new drugs for Crohn's disease, lymphoma pharmaphorum09:54

Yesterday

Long-Term Remission, OS With Cilta-Cel Sets New Benchmark for Survival Outcomes in R/R Myeloma OncLive21:31 9-Jul-25

New study could improve early lung cancer detection for Hodgkin lymphoma survivors University of Manchester15:15 9-Jul-25

Dad felt like he was ‘walking in flippers’ before cancer diagnosis The Independent11:00 9-Jul-25

Soil microbe could lead to new lymphoma treatment British Society for Haematology09:42 9-Jul-25

Researcher awarded £300k to study blood cancer treatment The Bolton News07:52 9-Jul-25

In the last 7 days

IsaKRD Induction Achieves 95% Response Rate in Multiple Myeloma Pharmacy Times21:40 8-Jul-25

Roy Herbst, MD, PhD, on Why It Is an 'Exciting Time' in Oncology and Hematology Medpage Today20:05 8-Jul-25

Updated EHA-EMN Guidelines Include Melphalan Flufenamide for R/R Myeloma OncLive17:43 8-Jul-25

Sequencing CAR T and Bispecifics for Multiple Myeloma: Tyler Sandahl, PharmD American Journal of Managed Care17:16 8-Jul-25

A new cell therapy for leukaemia shows high efficacy and safety in the laboratory ecancer15:08 8-Jul-25

Woman battles stage 4 lymphoma while five months pregnant ABC7 / WLS-TV16:56 7-Jul-25

New Lab Model to Help Find Treatments for Aggressive Blood Cancer Hospimedica15:56 7-Jul-25

Regeneron’s Lynozyfic granted FDA accelerated approval to treat multiple myeloma PMLiVE12:32 7-Jul-25

Clovis woman battles stage 4 lymphoma while five months pregnant ABC30 / KFSN-TV04:07 7-Jul-25

Planned C-sections linked to increased risk of developing childhood leukemia News-Medical.Net21:11 4-Jul-25

Planned C-sections increase the risk of certain childhood cancers ecancer14:37 4-Jul-25

New model to find treatments for an aggressive blood cancer University of Birmingham07:36 4-Jul-25

New lab model brings hope for aggressive blood cancer research News-Medical.Net04:50 4-Jul-25

Immune correlates of anti-Bcma car-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world… Nature.com02:54 4-Jul-25

Antibody-cancer drug combo shows promise against aggressive lymphoma ecancer13:50 3-Jul-25

Regeneron nabs dosing edge with Lynozyfic’s FDA approval in multiple myeloma Pharmaceutical Technology12:06 3-Jul-25

FDA grants accelerated approval to linvoseltamab-gcpt for relapsed or refractory multiple… ecancer11:37 3-Jul-25

Regeneron gets long-awaited FDA okay for myeloma drug pharmaphorum11:07 3-Jul-25

Engineers create first immunocompetent leukaemia device for CAR T immunotherapy screening ecancer10:26 3-Jul-25

New drug combination effective for T-cell lymphoma patients ecancer09:25 3-Jul-25

‘Leukaemia-on-a-chip’ could transform CAR T blood cancer treatments ecancer09:15 3-Jul-25

In the last month

New Bispecific T-Cell Engager Approved for Multiple Myeloma Medpage Today20:54 2-Jul-25

FDA Approves Linvoseltamab-Gcpt for Treatment of Relapsed or Refractory Multiple Myeloma Pharmacy Times17:26 2-Jul-25

FDA Approves Linvoseltamab for Relapsed/Refractory Multiple Myeloma OncLive17:23 2-Jul-25

FDA Approves Linvoseltamab to Treat R/R Multiple Myeloma American Journal of Managed Care17:22 2-Jul-25

New Miniature Device to Transform Testing of Blood Cancer Treatments Hospimedica16:21 2-Jul-25

Lynozyfic™ (linvoseltamab-gcpt) Receives FDA Accelerated Approval for Treatment of Relapsed or Refractory Multiple… Regeneron Pharmaceuticals (Press Release)16:06 2-Jul-25

Leukemia-on-a-chip offers breakthrough in personalized cancer treatment News-Medical.Net13:41 2-Jul-25

Clinical "Gray Areas" Persist Amid Evolving Multiple Myeloma Treatment Strategies OncLive13:38 2-Jul-25

For Your Myeloma Patients: Are You a Candidate for Autologous Stem Cell Transplant? Medpage Today13:36 2-Jul-25

The Wealth and Complexity of Treatment Options for Relapsed/Refractory Multiple Myeloma Medpage Today13:36 2-Jul-25

CHMP recommends tablet formulation of BeOne’s targeted cancer drug Brukinsa PMLiVE12:31 2-Jul-25

Pfizer terminates study of CD47 in blood cancer due to low recruitment Clinical Trials Arena11:33 2-Jul-25

Home care that may protect lymphoma patients from heart failure British Society for Haematology09:18 2-Jul-25

Timepoint at which B cells transform into leukemic cells impacts treatment outcomes News-Medical.Net05:52 2-Jul-25

Comprehensive machine learning analysis of PANoptosis signatures in multiple myeloma identifies prognostic and… Nature.com00:12 2-Jul-25

Cilta-Cel Spurs Remission Milestone—But Is It a Cure? Pharmacy Times23:28 1-Jul-25

Lower Tregs Linked With Survival in Multiple Myeloma American Journal of Managed Care21:13 1-Jul-25

DREAMM-20 Hints at a More Tolerable Path for BCMA-Targeted Therapy in Myeloma Medpage Today20:19 1-Jul-25

ASCO 2025: Age-Related Differences in Relapsed/Refractory ALL Treatment Outcomes Pharmacy Times19:13 1-Jul-25

Early SYRUS Data Highlight Safety, Efficacy of AZD0486 in Relapsed/Refractory B-Cell ALL: Ibrahim Aldoss, MD American Journal of Managed Care17:19 1-Jul-25

Approaches to Risk Stratification, Timing of Treatment Initiation Pose Challenges in Smoldering Myeloma OncLive21:16 30-Jun-25

Timepoint at which developing B-cells become cancerous impacts leukaemia treatment ecancer16:30 30-Jun-25

The Leukemia & Lymphoma Society at ASCO 2025: Blood cancers ... pharmaphorum15:07 30-Jun-25

FDA Removes REMS Programs for All Currently Approved CD19- and BCMA-Directed CAR T-Cell Therapies in Hematologic… OncLive14:39 30-Jun-25

Scots man who complained of 'sore nose' left with hole in face after cancer diagnosis Daily Record11:50 30-Jun-25

Scot's horror cancer diagnosis leaves him with no nose as he thanks hero medics Daily Record09:08 30-Jun-25

Highlighting Disparities in Myeloma Outcomes, the Impacts of Comorbidities American Journal of Managed Care21:30 28-Jun-25

SYRUS Study Explores AZD0486 Safety, Dosing in Relapsed/Refractory B-Cell ALL: Ibrahim Aldoss, MD American Journal of Managed Care17:15 28-Jun-25

FDA Takes Steps to Increase, Ease Access to CAR-T Therapies Bloomberg Law23:03 27-Jun-25

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma Pharmacy Times16:55 27-Jun-25

Tasquinimod Shows Some Activity in Myeloma Medpage Today16:45 27-Jun-25

Sanofi’s Sarclisa recommended by CHMP for new multiple myeloma indication PMLiVE12:37 27-Jun-25

Increasing the donor pool for haematopoietic stem cell transplantation ecancer11:21 27-Jun-25

Barts named blood cancer centre of excellence Barts Health NHS Trust (Press Release)09:24 27-Jun-25

Prescient advances new therapies for hard-to-treat cancers Stockhead05:37 27-Jun-25

Partial match stem cell transplants show strong survival rates News-Medical.Net04:11 27-Jun-25

NOBO Medicine wins KDDF support for phase 2 trial of BTK inhibitor in CNS lymphoma Korea Biomedical Review03:32 27-Jun-25

JNJ-5322 Demonstrates Preliminary Efficacy and Is Safe in R/R Multiple Myeloma OncLive22:18 26-Jun-25

New community support group launched to help blood cancer patients Medway NHS Foundation Trust (Press Release)16:54 26-Jun-25

Study demonstrates drug combination is well tolerated, safe and effective for patients with… ecancer16:12 26-Jun-25

FDA approves tafasitamab-cxix for relapsed or refractory follicular lymphoma ecancer15:51 26-Jun-25

Notorious anti-vaxxer mother of Cambridge grad, 23, who died of cancer after refusing… MailOnline12:52 26-Jun-25

Self-Administered Subcutaneous Isatuximab May Ease Multiple Myeloma Treatment Burden: Xavier Leleu, MD, PhD American Journal of Managed Care22:15 25-Jun-25

Risk Prediction Model for Early Hodgkin's Lymphoma Outperforms Widely Used Standard Medpage Today20:07 25-Jun-25

Trial Supports Subcutaneous Isatuximab as Effective Alternative to IV Version: Xavier Leleu, MD, PhD American Journal of Managed Care17:20 25-Jun-25

Quality of Life Disparities Persist in R/R Multiple Myeloma Despite Universal Health Care: Francesco Sparano, MSc American Journal of Managed Care17:20 25-Jun-25

Novel Targeted, Chemo-Free, and Cellular Therapies Are Poised to Transform Treatment Paradigms in B-Cell Malignancies OncLive15:14 25-Jun-25

Continuous Subcutaneous Lenalidomide Shows Promise in Reducing Toxicity in R/R Multiple Myeloma Pharmacy Times14:53 25-Jun-25

Long-Term Data Support Cilta-Cel Use in R/R Multiple Myeloma: Sundar Jagannath, MBBS American Journal of Managed Care14:17 25-Jun-25

J&J’s Darzalex recommended by CHMP to treat smouldering multiple myeloma PMLiVE12:29 25-Jun-25

Cigna Accuses Bristol-Myers of ’Sham’ Suits to Goose Drug Prices Bloomberg Law22:19 24-Jun-25

Unmasking Senescence in CAR T-cell Therapy: A Costimulation-Mediated Alliance or Adversity? Behavioural and Social Sciences at Nature Research21:58 24-Jun-25

In R/R Marginal Zone Lymphoma, 90% Alive at 2 Years After Liso-Cel American Journal of Managed Care21:30 24-Jun-25

Cigna sues Bristol Myers for alleged monopoly over blockbuster multiple myeloma drug Reuters17:42 24-Jun-25

Unveiling cutting-edge advances in CAR-T cell therapy for lymphoma ecancer16:29 24-Jun-25

CAR-T for Multiple Myeloma: How to Choose Between Therapies? Medpage Today15:57 24-Jun-25

Children’s Hospital of Philadelphia and St. Jude Researchers Find Genetic Ancestry Influences How Gene Mutations Impact … Newswise (Press Release)15:45 24-Jun-25

Sarclisa recommended for EU approval in newly diagnosed multiple myeloma Pharmafile15:14 24-Jun-25

Moving CAR-T Into Earlier Lines of Myeloma Treatment Medpage Today14:46 24-Jun-25

New Findings Highlight Key Role of Clinician Communication in Lymphoma, CLL Care: Lorna Warwick American Journal of Managed Care14:13 24-Jun-25

Scientists transform deadly ancient fungus into potential cancer cure MailOnline22:20 23-Jun-25

Next generation CAR-T cells push the boundaries of lymphoma treatment News-Medical.Net20:04 23-Jun-25

CHMP Recommends Isatuximab Plus VRd for Transplant-Eligible, Newly Diagnosed Myeloma OncLive15:56 23-Jun-25

First-Line Ibrutinib Plus Venetoclax Demonstrates Activity in Older Patients With MCL OncLive15:15 23-Jun-25

Cilta-Cel Continues to Sustain PFS and OS in Relapsed/Refractory Multiple Myeloma OncLive13:13 23-Jun-25

Hope to improve tazemetostat treatment for lymphoma British Society for Haematology09:54 23-Jun-25

Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple… Sanofi (Press Release)06:06 23-Jun-25

Five Under 5: Top Oncology Videos for the Week of 6/15 OncLive11:15 22-Jun-25

Impact of extranodal involvement at car T-cell therapy on outcomes in patients with relapsed or refractory large B-cell … Nature.com00:07 22-Jun-25

'I lost my mum to cancer then found a lump on the side of my neck' Somerset Live21:59 21-Jun-25

The OncFive: Top Oncology Articles for the Week of 6/15 OncLive11:10 21-Jun-25

FDA Approves Tafasitamab for Follicular Lymphoma American Journal of Managed Care18:12 20-Jun-25

UHNM research-supported ‘trojan Horse’ cancer drug approved by NHS offering breakthrough myeloma treatment University Hospitals of North Midlands (Press Release)16:09 20-Jun-25

BCMA CAR-T Yields 100% Response Rate in Small AL Amyloidosis Trial Medpage Today16:08 20-Jun-25

CHMP Recommends Ibrutinib Plus Chemoimmunotherapy for Frontline, Transplant-Eligible Mantle Cell Lymphoma OncLive16:00 20-Jun-25

DARZALEX® (daratumumab) receives the first positive CHMP opinion for patients with high-risk smouldering multiple… Johnson & Johnson (Press Release)14:00 20-Jun-25

IMBRUVICA® (ibrutinib) receives positive CHMP opinion for the treatment of patients with previously untreated mantle… Johnson & Johnson (Press Release)13:19 20-Jun-25

From Trial to Practice in the Evolving Landscape of Hematologic Malignancies Pharmacy Times05:20 20-Jun-25

CARTITUDE-4 Data Solidify Cilta-cel’s Role in RRMM: Surbhi Sidana, MD, MBBS American Journal of Managed Care16:15 19-Jun-25

Tafasitamab-Cxix With Rituximab, Lenalidomide Approved by FDA for Relapsed/Refractory Follicular Lymphoma Pharmacy Times15:56 19-Jun-25

FDA Approves Tafasitamab Plus Lenalidomide and Rituximab for R/R Follicular Lymphoma OncLive21:05 18-Jun-25

Bristol Myers Squibb to present positive new data on lymphoma treatment Pharmafile14:49 18-Jun-25

DVRd vs VRd in Transplant-Ineligible Myeloma: Insights From Saad Z. Usmani, MD, MBA American Journal of Managed Care14:18 18-Jun-25

Lyell reports new clinical data from trial of large B-cell lymphoma therapy Clinical Trials Arena12:33 18-Jun-25

Hope for rare blood cancer treatment British Society for Haematology10:59 18-Jun-25

Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma: a report… Nature.com06:25 18-Jun-25

view more headlines

10 Jul 17:06

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.